4 November 2019

Yvonne Veenhuizen, Alexander Geurts, theme Neurorehabilitation, Baziel van Engelen, theme Disorders of movement, and colleagues, showed that Energetic improves participation in patients with neuromuscular disease. They have published their results in Neurology.

Many patients with a neuromuscular disease (NMD) have chronic fatigue and need support to manage daily activities and  social participation. In the renowned medical journal Neurology Veenhuizen et al. showed in a randomized controlled trial that Energetic, a self-management group program combining aerobic training, energy conservation management, and relapse prevention, significantly improves social participation and functional endurance in patients with NMD and chronic fatigue. It was a multicentered study that showed that this program can be implemented in different health care settings in the Netherlands.
 

Related news items


1.5 million euro grant for research into earlier recognition of Parkinson's disease

27 October 2021

Researchers aim to improve identification of early symptoms and subtypes of Parkinson's disease with large international study

read more

BRAINMODEL: precision medicine for brain disorders

25 October 2021

A team of researchers from Radboudumc, VU Amsterdam and other institutes is going to look for new and better ways to heal developmental disorders in the brain.

read more

How healthy is James Bond? - A flu to a kill No time to die: the pathogens surrounding secret agent 007

21 October 2021

James Bond made a total of 25 films between 1962 and 2021. In all those films, secret agent 007 washed his hands only twice, even though he often stayed in not so hygienic places with considerable health risks. Radboudumc researchers examined all the health risks in the 47 countries Bond visited.

read more

Surprisingly dominant cause underlying type I congenital defect of glycosylation

21 October 2021

Alex Garanto, Melissa Bärenfänger, Mirian Janssen, and Dirk Lefeber published a new study, identifying a surprisingly dominant genetic cause underlying type I congenital defect of glycosylation with neuromusculoskeletal phenotypes.

read more

Sensitive blood-test as a patient-friendly alternative for bone marrow-based cancer monitoring

20 October 2021

Hans Jacobs and Pieter Langerhorst, theme Cancer development and immune defense, and colleagues are one step closer to implementation of personalized diagnostics for bone marrow-based cancer monitoring.

read more